Skip to main content

Table 2 Clinicopathological variables of 104 CRC patients and their correlation with PI3K (p110α) expression

From: Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway

Variables

All cases (N = 104; %)

Negative (N = 31; %)

Positive (N = 73; %)

P-values

Male

67 (64.4%)

18 (26.9%)

49 (73.1%)

0.382

Female

37 (35.6%)

13 (35.1%)

24 (64.9%)

 

≤65

66 (63.5%)

21 (31.8%)

45 (68.2%)

0.658

≥65

38 (36.5%)

10 (26.3%)

28 (73.7%)

 

M0

73 (70.2%)

27 (37.0%)

46 (63.0%)

0.018

M1

31 (29.8%)

4 (12.9%)

27 (87.1%)

 

PIK3CA wild-type

67 (64.4%)

28 (41.8%)

39 (58.2%)

< 0.001

PIK3CA mutant

37 (35.6%)

3 (8.1%)

34 (91.9%)